 |
|
Public information about osteoporosis: what's available, what's needed?
U.S. Government
Paperback. Books LLC, Reference Series 2011-10-01.
ISBN 9781234212803
|
|
|
|
Buy from Amazon.com
|
Publisher description
Original publisher: [Washington, D.C.] : Office of Technology Assessment, Congress of the U.S. : [Supt. of Docs., U.S. G.P.O., distributor, 1994]. LC Number: RC931.O73 P83 1994 OCLC Number: (OCoLC)30988308 Subject: Osteoporosis. Excerpt: ... -..-Public Information About Osteoporosis: What's Available, What's Needed? 17 Etidronate a medication that has been considered for the prevention and treatment of osteoporosis for IS many years It known to reduce bone loss and was approved by the Food and Drug Administration IS ( FDA ) for treatment of Paget's disease in 1977 and for two other conditions in 1979 and 1987. Etidronate has not been approved by the FDA for the prevention or treatment of osteoporosis On May 3, 1990, the published the results of a three-year, random-New England Journal of Medicine ized, double-blind, placebo-controlled study conducted in Denmark which found that spinal bone density was significantly Increased in 20 postmenopausal women who took etidronate compared with 20 post-menopausal women who did not take etidronate ( 1 10 ). In the last two years of the study, the rate of new spinal fractures was significantly lower for the women who took etidronate, but there was no significant difference in the rate of new spinal fractures in the two groups over the full three-year period of the study. The average age of the women in the study was 68 All the women had low bone density and at least one but not more than four spinal fractures at the start of the study. published the results of a second two-year, New England Journal of Medicine On July 12, 1990, the randomized, double-blind, placebo-controlled study conducted at seven sites in the United States which found that spinal bone density was significantly Increased in 195 postmenopausal women who took etidro-nate compared with 183 postmenopausal women who did not take etidronate ( 131 ) In this study, however, the women who took etidronate had half as many new spinal fractures as the women who di
More books by U.S. Government
Similar books
Rate the book
Write a review and share your opinion with others. Try to focus on the content of the book. Read our instructions for further information.
Public information about osteoporosis: what's available, what's needed?
Book reviews » Public information about osteoporosis: what's available, what's needed?
|
|
 |
|
|
|
|
